Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer.

MLA

Lei, Ming, et al. “Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 14, July 2021, pp. 3926–35. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-20-2790.

APA

Lei, M., Siemers, N. O., Pandya, D., Chang, H., Sanchez, T., Harbison, C., Szabo, P. M., Janjigian, Y., Ott, P. A., Sharma, P., Bendell, J., Evans, T. R. J., de Braud, F., Chau, I., & Boyd, Z. (2021). Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(14), 3926–3935. https://doi.org/10.1158/1078-0432.CCR-20-2790

Chicago

Lei, Ming, Nathan O Siemers, Dimple Pandya, Han Chang, Teresa Sanchez, Christopher Harbison, Peter M Szabo, et al. 2021. “Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27 (14): 3926–35. doi:10.1158/1078-0432.CCR-20-2790.